FNY Investment Advisers’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,000
Closed -$100K 890
2023
Q4
$100K Buy
+10,000
New +$100K 0.11% 130